Response to proposed research to reverse brain death: more than regulatory failure.
Indian J Med Ethics
; 1(3): 134-7, 2016.
Article
em En
| MEDLINE
| ID: mdl-27474692
ABSTRACT
In early May 2016, reports of a bizarre study to attempt a reversal of brain death made the headlines, but there was not even a squeak from the authorities. The "Reanima Project" is a collaboration between an Indian surgeon, Himanshu Bansal, and a US-based biotech company, Bioquark Inc. The research will be conducted by Bansal's own biotech company, Revita Life Sciences, at his Anupam hospital in Rudrapur, a city in Uttarakhand state.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Morte Encefálica
/
Má Conduta Científica
/
Pesquisa Biomédica
/
Ética em Pesquisa
/
Ética Médica
/
Hospitais
Tipo de estudo:
Prognostic_studies
Aspecto:
Ethics
Limite:
Humans
País/Região como assunto:
America do norte
/
Asia
Idioma:
En
Revista:
Indian J Med Ethics
Assunto da revista:
ETICA
Ano de publicação:
2016
Tipo de documento:
Article